Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytokinetics (NQ: CYTK ) 56.51 +0.01 (+0.02%) Streaming Delayed Price Updated: 11:00 AM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cytokinetics < Previous 1 2 3 4 5 6 7 Next > Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 December 10, 2021 Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: Via Benzinga The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré December 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome... Via Benzinga Expert Ratings For Cytokinetics October 07, 2021 Cytokinetics (NASDAQ:CYTK) has observed the following analyst ratings with... Via Benzinga The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More December 06, 2021 The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... Via Benzinga Exposures Product Safety Cytokinetics, Incorporated (CYTK) Q3 2021 Earnings Call Transcript November 04, 2021 CYTK earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Where Cytokinetics Stands With Analysts October 08, 2021 Over the past 3 months, 6 analysts have published their opinion on Cytokinetics (NASDAQ: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021 October 07, 2021 Upgrades For State Street Corporation (NYSE: Via Benzinga Cramer Weighs In On Cytokinetics, LegalZoom And Matterport September 29, 2021 On CNBC's "Mad Money Lightning Round," Jim Cramer said Cytokinetics, Inc. (NASDAQ: CYTK) is a very good spec. Big pharma needs these companies, he added. LegalZoom.... Via Benzinga The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout October 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... Via Benzinga The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO October 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... Via Benzinga Exposures Product Safety Cytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript August 06, 2021 CYTK earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive September 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (... Via Benzinga Cytokinetics: Q2 Earnings Insights August 05, 2021 Shares of Cytokinetics (NASDAQ:CYTK) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 26.47% over the past... Via Benzinga Cell Analysis Instruments Provider Cytek Biosciences Kick Starts Trading After Pricing IPO At $17 July 23, 2021 Cytek Biosciences Inc (NASDAQ: CTKB) shares started trading today after its initial public offering was priced to raise about $200 million for the cell-analysis Company.... Via Benzinga Topics Initial Public Offering Exposures Securities Market The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold September 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... Via Benzinga Why Cytokinetics (CYTK) Shares Are Trading Higher Today? July 20, 2021 Cytokinetics Incorporated (NASDAQ: CYTK) shares continue to move forward after it announced positive REDWOOD-HCM Phase 2 data for CK-274 and garnered favorable comments... Via Benzinga The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical August 31, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga 10 Biggest Price Target Changes For Tuesday July 20, 2021 Citigroup boosted International Business Machines Corporation (NYSE: Via Benzinga The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts August 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street July 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... Via Benzinga 54 Biggest Movers From Yesterday July 20, 2021 Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon... Via Benzinga Why Is Cytokinetics Inc. (NASDAQ: CYTK) The Best Stock of the Day? July 19, 2021 Founded in 1997, Cytokinetics Inc. focuses on muscle biology, developing muscle activators and inhibitors that improve overall function. These medications most often serve... Via Benzinga Dow on Pace for Worst Day of 2021 as Covid-19 Fears Weigh July 19, 2021 The Dow Jones Industrial Average is down more than 760 points at midday and is eyeing its worst daily drop for 2021. Via Talk Markets Topics Stocks Exposures COVID-19 US Equities Here's Why Cytokinetics Is Rocketing Higher Today July 19, 2021 The company's new heart drug candidate produced encouraging clinical trial results. Via The Motley Fool Mid-Day Market Update: Crude Oil Dips 6%; Cytokinetics Shares Spike Higher July 19, 2021 Midway through trading Monday, the Dow traded down 2.28% to 33,896.40 while the NASDAQ fell 1.31% to 14,238.93. The S&P also fell, dropping 1.74% to 4,251.79. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 30 Stocks Moving In Monday's Mid-Day Session July 19, 2021 Gainers Cytokinetics, Incorporated (NASDAQ: CYTK) jumped 56.4% to $30.07 after the company disclosed topline results from Cohorts 1 and 2 of REDWOOD-HCM. Aehr Test Systems (... Via Benzinga CYTK Stock Flies High on Exciting Drug Trial Results July 19, 2021 CYTK stock is being boosted by bullish biopharma buyers today. The company is reporting with optimism regarding its newest HCM treatment. Via InvestorPlace How Strong Cytokinetics Test Results Could Undermine Bristol Myers' $13.1 Billion Buyout July 19, 2021 Cytokinetics said Monday its treatment improved blood flow for patients with a genetic heart disease, and the biotech stock sprinted. Via Investor's Business Daily < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.